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ABSTRACT
We report here the isolation of 44 genes that are
upregulated after serum starvation and/or contact
inhibition. These genes have been termed TIGA,
after Transcript Induced by Growth Arrest. We found
that there are two kinds of G0 phases caused by
serum starvation, namely, the shallow G0 (or G0/G1)
and the deep G0 phases. The shallow G0 is induced
by only a few hours of serum starvation, while
deep G0 is generated after 3 days of serum
starvation. We propose that mammalian cells enter
deep G0 through a G0 gate, which is only opened
on the third day of serum starvation. TIGA1, one of
the uncharacterized TIGA genes, encodes a homo-
log of cyanate permease of bacteria and localizes
in mitochondria. This suggests that Tiga1 is invol-
ved in the inorganic ion transport and metabolism
needed to maintain the deep G0 phase. Ectopic
expression of TIGA1 inhibited not only tumor
cell proliferation but also anchorage-independent
growth of cancer cell lines. A microsatellite marker,
ENDL-1, allowed us to detect loss of heterozygosity
around the TIGA1 gene region (5q21–22). Further
analysis of the TIGA genes we have identified here
may help us to better understand the mechanisms
that regulate the G0 phase.
INTRODUCTION
Most of the cells in adult eukaryotic organisms do not divide.
Instead, they remain in a state called the quiescent state or G0
phase in which macromolecular synthesis is largely reduced.
There are at least three distinct conditions that induce eukar-
yotic cells to enter this quiescent state, namely, serum star-
vation, contact inhibition and terminal differentiation. We
distinguish here between the states that are induced by
these conditions by referring to them as G0-s, G0-c and
G0-t, respectively. It is likely that the mechanisms that
regulate these states share some similarities but diverge in
other aspects. Normal somatic cells require the presence of
mitogens for continual proliferation; upon the removal of
such mitogens or upon contact inhibition, they exit the vege-
tative cell cycle at early/mid G1 phase and proceed to the G0
phase. In contrast, cancer cells are destined to repeat the cell
cycle indeﬁnitely and cannot be induced to enter the G0
phase by either serum starvation or contact inhibition.
Deﬁning the G0 phase is hampered by difﬁculties in distin-
guishing it from the G1 phase. Consequently, the arrest point
is sometimes referred to as G0/G1. More than a quarter of a
century ago, the arrest point was ﬁrst described as a restric-
tion point that regulates cell growth and the division cycle
(1). Zetterberg and Larsson (2) proposed that this restriction
point divides the G1 phase into two parts; cells before this
point can leave the cell division cycle and enter the G0
phase, while cells past this point are unaffected by a short
period of serum deprivation. However, on the basis of his
continuum model, Cooper (3) argued that a restrictive control
point does not exist. Thus, not only are there no deﬁned
physiological or molecular markers that can be used to
distinguish between the G0-s, G0-c and G0-t phases, the
general nature of the G0 phase itself is poorly deﬁned.
It has been revealed that the transition from G0 to G1 (G0/
G1) is regulated in an analogous fashion to S phase entry, as
it involves the inactivation of the retinoblastoma (Rb) protein
by phosphorylation. Evidence for this is that acute somatic
inactivation of Rb is sufﬁcient to induce G0-arrested cells
to re-enter the cell cycle (4). Moreover, the acute loss of
Rb expression in primary quiescent cells due to an Rb muta-
tion is also sufﬁcient to induce their entry into the cell cycle
entry (5). However, a different cyclin/cdk combination to the
one involved in S phase entry mediates the Rb inactivation
event in the G0/G1 transition, as it has been shown that cyclin
C combines with Cdk3 during the G0/G1 transition and that
this leads to the phosphorylation of Rb and the efﬁcient exit
of these cells from G0 (4). Moreover, it has been found that
*To whom correspondence should be addressed. Tel: +81 6 6875 3980; Fax: +81 6 6875 5192; Email: snj-0212@biken.osaka-u.ac.jp
Present address:
Naohisa Yoshioka, Howard Hughes Medical Institute, Department of Cellular and Molecular Medicine, UCSD School Medicine, 9500 Gilman Drive, La Jolla,
CA 92093-0686, USA
  2006 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
4878–4892 Nucleic Acids Research, 2006, Vol. 34, No. 17 Published online 14 September 2006
doi:10.1093/nar/gkl651the E3 complex KPC (Kip1 ubiquitination-promoting
complex) plays a role in releasing the cells from G0 to G1
by degrading the cyclin-dependent kinase inhibitor p27
(Kip1) (6). Notably, E2F-6, which can silence genes in an
Rb-independent manner, may also be involved in gene silen-
cing in the G0 phase, as a multimeric E2F-6 complex that
contains chromatin modiﬁers and Myc/Brachyury-binding
regulators has been found to preferentially occupy target
promoters in G0 cells rather than in G1 cells. This suggests
that this complex participates in the silencing of the E2F-
and Myc-responsive genes in quiescent cells (7).
It has been proposed that important regulatory factors
are expressed in a G0 phase-speciﬁc manner to initiate and
maintain the quiescent state. However, only a few studies
have succeeded in isolating such genes or factors. In one
such study, six growth-arrest-speciﬁc (gas) genes were iso-
lated from serum-starved mouse cells (8). Of these genes,
Gas1 was found to function during development as an inhibi-
tor of growth and a mediator of cell death (9). Gas2 is an inhi-
bitor of calpain, as it controls its transcript levels (10).
However, determining the function of these gas genes has
shed only limited light on the G0 phase, partly because so
many of the genes that characterize the G0 phase have not
yet been isolated and identiﬁed. Moreover, since the studies
characterizing the gas genes focused on genes expressed in
G0-s, the genes regulating G0-c and G0-t have not yet been
explored.
To examine these issues further, we here report the isola-
tion of novel genes that are upregulated after serum starvation
and contact inhibition. We selected the putative G0-speciﬁc
genes that are upregulated by serum starvation but not by
contact inhibition for further characterization. We propose
here that there are two kinds of G0 phases caused by serum
starvation, namely, the shallow G0 (or G0/G1) and the deep
G0 phases, and that there exists an entry point (the G0 gate)
that is opened after 3 days of serum starvation. We show here
that the shallow G0 is induced by a few hours of serum star-
vation, while the deep G0 phase is generated after 3 days of
serum starvation.
MATERIALS AND METHODS
Cell lines and culture conditions
The normal human diploid ﬁbroblast line TIG-1 was grown in
DMEM supplemented with 10% FBS. For serum starvation,
subconﬂuent cells were cultured for 96 h in DMEM contain-
ing 0.5% FBS. The six SCLC cell lines Lu-24, Lu-130,
Lu-134-A, Lu-135, Lu-139, Lu-140 and H69; the six
NSCLC cell lines A549, EBC-1, Lu-65, HEL, Jurkat and
Raji are gifts from RIKEN Cell bank (Tokyo, Japan). PC-3,
PC-7 and PC-10 cells are gifts from Dr T. Kohno (National
Cancer Center Research Institute, Tokyo, Japan). These cell
lines were grown in RPMI1640 medium supplemented with
10% FBS. The other cell lines, MRC-5, HeLa S3, MCF-7,
Saos-2, T24 and EcR-293, were maintained in DMEM
supplemented with 10% FBS.
Virus infection and soft agar assay
pCXbsr-HA-Tiga1 was constructed by ligating the
EcoRI–NotI fragments of HA-tagged TIGA1 from
pcDNA3-HA-TIGA1 into the EcoRI and NotI sites of
pCXbsr, a Moloney murine leukemia virus (MuLV)-based
retrovirus vector containing the blasticidin S resistance gene
(bsr) as a selectable marker (11). Production of amphotropic
retroviruses, virus infection of cancer cells and the soft agar
assay were performed as previously described (11,12).
Brieﬂy, BOSC23 cells were co-transfected with pCXbsr-
HA-Tiga1 and pCL-Ampho vector and incubated for 48 h.
The culture supernatants were collected as amphotropic
viral stocks. For virus infection, growing Saos-2 and T24
cells were treated with 8 mg/ml polybrene for 30 min and
then incubated with the amphotropic retrovirus for 1 h at
37 C. After the blasticidin S (10 mg/ml) selection, cells
were pooled and used for the experiments. For the soft agar
assay, 10000 growing cells were inoculated into 0.4%
Noble agar containing DMEM supplemented with 10% FBS
in a 60 mm dish. After 10 days of incubation, the number
of colonies (>0.15 mm in diameter) in each plate was scored.
Preparation and expression of a fluorescent fusion
protein of Tiga1
To prepare a plasmid construct that can express Tiga1 protein
fused with enhanced green ﬂuorescent protein (GFP), we ﬁrst
produced a DNA fragment carrying the entire ORF of Tiga1
by PCR using TIGA1 cDNA as a template. To obtain the
cDNA insert for Tiga1 carrying in-frame AscI–NotI sites,
primers hybridizing to TIGA1 around the initiation codon
(50-AGAATCCGGCGCGCCGATGGTACAGCCCGCT-30;
the AscI site is underlined) and the termination codon (50-
ATACTCGAGGCGGCCGCTCAGTTATACGGTAAGGC-
30; the NotI site is underlined) were synthesized and used in
PCR. The resulting sequence was conﬁrmed to be the TIGA1
gene by sequencing the DNAs of three independent clones.
The plasmid DNA without any mismatches was selected.
Next, we incorporated the AscI/NotI-digested fragment of
TIGA1 into the pEGFP3B vector. COS-7 cells were trans-
fected with the plasmid DNA harboring EGFP-TIGA1 or
the vector alone by using lipofectamine reagents (Invitrogen,
San Diego, CA) according to the manufacturer’s protocol and
cultured in a 60 mm culture dishes at 37 Ci naC O 2 incubator
for 48 h, and were ﬁxed as described previously (13,14).
Photo images were recorded under a ﬂuorescence microscope
(Olympus, IX51).
Western blot analysis and protease protection assay
The transfection of plasmids into HeLa or MCF-7 cells,
Western blot analysis and immune ﬂuorescence analysis
were performed as described previously (13). For western
blot analysis, the proteins of the transfected cells were
extracted in RIPA buffer after being washed with PBS( ),
followed by electrophoretic separation and probing with anti-
bodies against GFP (J1, a gift from Dr S. Fujita, Mistubishi
Kasei, Tokyo, Japan), tubulin (Sigma, Milwaukee, WI), cyto-
chrome c (Promega, Madison, WI) and Myc (PL14; MBL,
Ina, Japan). Chloromethyl-X-rosamine (MitoTracker Red)
was purchased from Molecular Probes Inc. (Eugene, OR).
The protease protection assay was performed as described
previously (13). Brieﬂy, cells extracts from 6Myc-Tiga1-
expressing HeLa cells were digested by various amounts of
trypsin in the presence or absence of 1% Triton X-100 for
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as described previously (14). The trypsin digestion was
rapidly inhibited by adding sample buffer and boiling. The
boiled extracts were probed by western blot analysis using
anti-Myc antibody.
RESULTS
Isolation of human TIGA genes
To isolate the human genes whose expression is upregulated
in growth-arrested human embryo ﬁbroblast TIG-1 cells, we
ﬁrst plated TIG-1 cells in DMEM supplemented with 10%
FCS and then reduced the FCS concentration to 0.5% when
they were in a semi-conﬂuent state. The cells were cultured
for 1–6 days in these serum-starved conditions and equal
numbers were harvested daily and subjected to mRNA
extraction. The daily mRNAs were used for time-course
northern blot analysis and pooled to construct a cDNA library
with the pAP3neo vector (15) (see Supplementary Data).
Northern blot analysis using the MCM2-7 genes as probes
and the mRNAs obtained from the cells at 0–6 days after
serum starvation was performed to conﬁrm that the serum-
starved cell population had actually entered the G0 phase
of the cell cycle. We showed previously that the MCM2-7
genes, which play pivotal roles in initiating the S phase of
the cell cycle, are dramatically upregulated at the G1/S tran-
sition after being induced by the addition of serum to exit the
G0 phase (16). Indeed, three days after serum deprivation,
the MCM2-7 mRNA levels in TIG-1 cells were markedly
reduced (Figure 1A). Thus, the serum deprivation induced
the cell population to enter a quiescent state.
We subjected the cDNA library constructed from these
quiescent cells to the stepwise subtraction method we devel-
oped previously (17). In this process, we subtracted the
cDNA clones that hybridized with the biotin-labeled mRNA
obtained from exponentially growing TIG-1 cells by biotin–
avidin interaction. This subtractive process was repeated
four times in a stepwise manner. The genes that showed con-
spicuously stronger band intensities after serum starvation
compared to the exponentially growing state (Log) in north-
ern blot analysis were selected as potential growth-arrest-
speciﬁc genes (data not shown). As a result, after the fourth
stepwise subtraction, we isolated 44 cDNA clones that
showed increased expression in the TIG-1 cells after serum
starvation. These genes were collectively named TIGA after
Transcript Induced by Growth Arrest (Table 1).
Time-course of TIGA mRNA expression after serum
starvation and contact inhibition
To examine when during the process of entry into G0 phase
each of the 44 TIGA genes become transcribed, we performed
time-course northern blot analysis using the RNA extracted
daily from TIG-1 cells over the six days of serum starvation
(Figure 1B and C; Supplementary Figure S1B, left panels).
We also examined whether these TIGA genes are induced
by cell-cell contact, which inhibits cell proliferation
(Figure 1B and C; Supplementary Figure S1, right panels).
This was because the growth arrests that arise from contact
A
C
B
Figure 1. Time-course northern blot analyses of TIG-1 cells. (A) Analysis of MCM gene expression by TIG-1 cells over 6 days of serum starvation. (B and C)
Analysis of the expression of the Group I (B) and Group II (C) TIGA genes (C) by TIG-1 cells over the 6 days of serum starvation (left panels) and the 2–10 days
of contact inhibition (right panels). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as a loading control. The size in kilobases (kb) of the mRNA
for each TIGA gene is shown on the right side of each panel.
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different types of cellular programs (18). For this purpose,
we allowed TIG-1 cells to grow to conﬂuency in the presence
of 10% FCS. The cells were harvested daily over the follow-
ing 2–10 days and total RNA was extracted and subjected to
northern blots using each TIGA cDNA insert as a probe.
Based on the time-course variation in the band intensity
(mRNA level) of each TIGA gene during serum starvation
and contact inhibition, we classiﬁed the genes into three
groups as described below. Notably, the mRNA levels of
GAPDH, which were originally going to serve as a loading
control, decreased markedly by the 2–3 day transition point
in serum starvation. This further demonstrates that after
this point, the basic metabolic activity that is supported by
glycolysis is downregulated.
The Group I genes (Figure 1B) showed abrupt upregulation
of their mRNA levels at 3 days after serum starvation, but
no or weak expression at 0–2 days (Figure 1B, left panels).
This suggests that these genes play a pivotal role in the
induction and/or maintenance of the G0 phase. Many of
these upregulations in mRNA levels are probably due to
elevated transcription. However, we cannot rule out the
possibility that some of these upregulations could also be
due to increased mRNA stability, particularly with regard
to the genes that showed weak expression at Days 0–2
after serum starvation (e.g. TIGA105, TIGA106, TIGA113,
TIGA119 and TIGA120). Given that Day 3 is when the
MCM2-7 mRNAs suddenly disappeared (Figure 1A), these
results suggest that cells enter the G0 phase at 3 days after
serum starvation; this entry point is likely to involve a distinct
mechanism. The other Group I TIGA genes showed very low
mRNA levels during logarithmic growth (Day 0). TIGA118
differs from the other Group I genes because while it
displayed an abrupt increase in mRNA levels at 2–3 days,
its mRNA levels subsequently decreased gradually. This
suggests that this gene may participate in the initiation of
the G0 phase rather than its maintenance. TIGA104 [alpha-
2-macroglobulin (A2M)] is also remarkable because it
shows conspicuous transcriptional induction in both the
deep G0-s (Day 6) and the deep G0-c phases (Day 10),
although its expression levels are very low until Days 2 or
4 after serum starvation or contact inhibition, respectively.
Notably, TIGA14, TIGA16 and TIGA120 had very low levels
of transcriptional induction during contact inhibition, which
suggests these genes play speciﬁc roles in the G0-s phase.
In contrast, TIGA104, TIGA111 and TIGA122 displayed
conspicuous transcriptional induction 6 days after contact
inhibition, which suggests that they participate in both G0-s
and G0-c.
The Group II genes display a gradual increase in mRNA
levels during Days 1–6 of serum starvation (Figure 1C, left
panels). Apart from TIGA110 (bone morphogenic protein
4), these TIGA genes were all expressed at low levels at the
logarithmic growth phase (Day 0). This suggests that these
genes play a role in the vegetative growth phase as well.
TIGA6 (transcription factor 21; TCF21) and TIGA110 are
remarkable because they show conspicuous transcriptional
induction in both the deep G0-s (Day 6) and the deep G0-c
phases (Day 10). Also notable are TIGA17 and TIGA18,a s
their mRNA levels peak around Day 3 and then gradually
decrease.
The Group III genes displayed greater upregulation of
mRNA levels during contact inhibition than during serum
starvation (Supplementary Figure S1). These results suggest
that the quiescent states caused by serum starvation (G0-s)
and contact inhibition (G0-c) differ in a fundamental way.
Thus, unlike the Group I genes, the Group II and III genes
may participate in growth arrest in general, and thus may
be less useful in helping us to understand G0-s.
From these results, we concluded that there are two kinds
of G0 phases caused by serum starvation, namely, the shallow
G0 (or G0/G1) and the deep G0 phases. We propose an entry
point (the G0 gate) that is opened after 3 days of serum star-
vation but is not necessarily opened by contact inhibition, and
that eukaryotic cells are led into the deep G0 phase through
this gate.
Table 1. List of TIGA genes
TIGA# Sequence description
TIGA1 Unknown (This work)
TIGA2 Unknown (RP11-201E8)
TIGA3 Bardet-Biedl syndrome 1 (BBS1)
TIGA4 Unknown
TIGA5 Podocan (IMAGE:4938380)
TIGA6 Transcription factor 21 (TCF21)
TIGA7 Unknown (IMAGE:4184613)
TIGA8 Unknown
TIGA9 Paralemmin
TIGA10 C1 domain-containing phosphatase and tensin-like
protein (C1-TEN)
TIGA11 Unknown
TIGA12 Serologically defined breast cancer antigen 84
TIGA13 Mitogen-activated protein kinase kinase kinase kinase
4 (MAP4K4)
TIGA14 Alstrom syndrome 1 (ALMS1)
TIGA15 Pleckstrin homology-like domain, family A
(IMAGE:5315177)
TIGA16 DEPP (decidual protein induced by progesterone)
TIGA17 Unknown (IMAGE:3460701)
TIGA18 Kidney predominant protein NCU-G1
TIGA19 TEA domain family member 3
TIGA20 Eukaryotic translation initiation factor 3 (eIF3)
TIGA21 Similar to complement receptor type 2 precursor
TIGA102 Retinoic acid receptor responder3 class II tumor
suppressor
TIGA103 Smoothened (SMO)
TIGA104 Alpha-2-macroglobulin
TIGA105 NuMA (nuclear mitotic apparatus protein)
TIGA106 EXT1,putativetumorsuppressor genehormonereceptor
TIGA107 OXA1
TIGA108 v-erbA-related ear-3 gene
TIGA109 Similar to human connective tissue growth factor
TIGA110 Bone morphogenetic protein 4 (hBMP-4)
TIGA111 Vitamin D3-upregulated protein 1 (VDUP1)
TIGA112 Gelsolin
TIGA113 TGF-bR8545;a
TIGA114 p8 protein (p8)
TIGA115 Complement compornent 1, r subcomponent (C1R)
TIGA116 Elastin microfibril interface-located protein (EMILIN)
TIGA117 Fibulin1 (FBLN1)
TIGA118 Manganese superoxide dismutase (MnSOD-2)
TIGA119 LIM domain kinase 1(LIMK1)
TIGA120 Similar to C53 CDK5 activator-binding protein
(FLJ21805)
TIGA121 Highly similar to nucleobindin precursor (FLJ21805)
TIGA122 Prostaglandin D2 synthase (PTGDS)
TIGA123 Sry-related high mobility group box 4 (SOX4)
TIGA124 LIV-1 protein, estrogen-regulated (LIV-1)
Nucleic Acids Research, 2006, Vol. 34, No. 17 4881Some TIGA genes are candidate tumor suppressors
Unlike normal somatic cells, cancer cells are destined to
repeat the cell cycle indeﬁnitely and cannot be induced to
enter the G0 phase by either serum starvation or contact inhi-
bition. Therefore, if some of the TIGA genes play pivotal
roles in maintaining growth arrest, they are expected to be
the tumor suppressor genes. Indeed, we found that the follow-
ing TIGA genes were already reported as candidate tumor
suppressor genes.
TIGA6, that encodes a transcription factor 21 (TCF21 ¼
POD1), was reported to be a tumor suppressor gene that
is frequently lost in human malignancies (19). POD1 is
a basic-helix–loop–helix (bHLH) transcription factor that
is highly expressed in the mesenchyme of developing
organs and in glomerular visceral epithelial cells (podocytes).
Pod1 is essential for the normal development of the testes
and ovaries and consequently for sexual differentiation.
Pod1 knockout (KO) mice die in the perinatal period with
multiple renal defects and Pod1 transcriptionally represses
steroidogenic factor 1 (Sf1), which regulates the expression
of multiple genes (20). Thus, the expression of Pod1 in
the deep G0 phase may either enhance or repress unknown
target genes.
TIGA111 encodes vitamin D3-upregulated protein 1
(VDUP1), which is a stress-response gene that is upregulated
by vitamin D3 and is considered to be a tumor suppressor
gene because it alters p27(kip1) stability by regulating
JAB1 (21). Indeed, expression of VDUP1 is frequently lost
in tumor tissue and cell lines and its ectopic expression sup-
presses cellular proliferation along with inducing cell cycle
arrest at the G1 phase (22).
TIGA106 encodes exostosin-1 (EXT1) that catalyzes,
together with EXT2, the formation of heparan sulfate (HS)
chains. Mutations in either EXT1 or EXT2 cause hereditary
multiple exostosis, which is an autosomal dominant disorder
characterized by the formation of a cartilage-capped tumor
(23). Thus, the EXT1 gene is a putative tumor suppressor
gene. HS proteoglycans are ubiquitous on the cell surface
and in the extracellular matrix, where they regulate signaling
molecules such as transforming growth factor-b (TGF-b)b y
forming HS chains.
TIGA113 encodes the type II receptor of TGF-b.
TGF-b has been implicated as both a tumor suppressor
and a tumor promoter in many solid epithelial cancers.
TGF-b initiates signaling by binding to type I or II receptors
and induces G0/G1 arrest through the Smad3-dependent
induction of the cyclin-dependent kinase inhibitor
p15(Ink4b) (24).
TIGA118 encodes manganese superoxide dismutase-2
(MnSOD-2), a antioxidant enzyme that scavenges superoxide
anions and is an important modulator of nitric oxide bio-
availability. Moreover, treatment of antioxidant induces
the G1 cell cycle arrest (25). SOD-2 has been postulated
to be a tumor suppressor and its identiﬁcation as a TIGA
gene is consistent with previous observations showing
that overexpressing MnSOD activity inhibits the growth of
cultured human prostate carcinoma cells (26), and that
SOD-2 is one of the downstream mediators of the
senescence-associated tumor-suppressing effect of mac25/
IGFBP-rP1 (27).
TIGA1 encodes a small protein with a single
transmembrane domain
To understand the physiological signiﬁcance of the TIGA
genes we identiﬁed, we selected TIGA1 for further analysis.
This gene was selected because it maps to the 5q21–q22
region where the adenomatosis polyposis coli (APC) gene
is localized. The deletion of the 5q21-q22 region is believed
to cause familial adenomatous polyposis (28). Since loss of
heterozygosity (LOH) in the 5q21–q22 region has also been
frequently observed in small-cell lung carcinoma (SCLC) as
well as non small-cell lung carcinoma (NSCLC), it has been
predicted that this region also contains unknown tumor sup-
pressor genes other than APC; TIGA1 is identical to one of
the candidates, LI33 (29).
TIGA1 belongs to the Group I TIGA genes and shows
no expression at the mitotic growth phase (Day 0 of
Figure 1B), very low expression on Days 1–2 of serum star-
vation, and then abrupt transcriptional induction on Day 3
(Figure 1B). In contact inhibition, while TIGA1 did display
weak transcriptional induction at Day 3, its expression levels
remained constant thereafter. Thus, TIGA1 seems to function
speciﬁcally in response to serum starvation. It is notable that
the TIGA1 cDNA sequences registered in the databank con-
tain a large number of mutations in not only the non-coding
region but also the ORF (Supplementary Figure S2). More-
over, some of the mutations caused amino acid changes or
generated stop codons that could have deleterious effects on
Tiga1 function. On the basis of this, we surmised that TIGA1
mutations may be involved in lung carcinogenesis. Our
reasoning will be discussed later.
TIGA1 encodes a small protein (Tiga1; 120 amino acids)
that has a transmembrane domain without a signal peptide
motif (Figure 2A). Northern blot analysis indicated that the
TIGA1 gene generates two transcripts. The 0.8 kb transcript
that can produce Tiga1 protein is ubiquitously detected in
all human tissues examined (Figure 2B), which is logical
because all of these tissues contain many cells in the quies-
cent state (G0 phase) and TIGA1 mRNA is abundant in this
state (Figure 1B). It remains unknown why the 2.9 kb trans-
cript is observed faintly in many tissues and strongly in the
brain, pancreas, spinal cord and kidney (Figure 2B). We
also examined the expression of the TIGA1 gene in lung
cancer cell lines and found that the TIGA1 mRNA levels
were almost undetectable in EBC-1, Lu-134-A and Lu-140
and very low in Lu-65, Lu-130 and Lu-135 (Figure 2C).
Unlike all the other lines, Lu-139 displayed high levels of
TIGA1 expression primarily because this cell line alone did
not display LOH around the TIGA1 gene as will be shown
later (Figure 7C) and thus has an extra allele.
Western blot analysis of Tiga1 expression
To analyze Tiga1 protein expression, we raised a polyclonal
anti-Tiga1 rabbit antibody by using afﬁnity-puriﬁed
GST-Tiga1 protein as the antigen. To determine whether
the antibody speciﬁcally recognizes Tiga1 protein, we gene-
rated Escherichiacoli cells transfected with a GST-Tiga1-
expressing plasmid. These cells were incubated at either 20
or 37 C with isopropyl b-D-thiogalactoside (IPTG), which
induces GST-Tiga1 protein expression. Cells that were not
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blot analyses using either an anti-GST antibody or the
afﬁnity-puriﬁed anti-Tiga1 antibody revealed both antibodies
recognized bands that had the expected size of the GST-Tiga1
protein (the 27 kDa GST tag plus 13kDa ¼ 40 kDa). Thus,
the anti-Tiga1 antibody speciﬁcally recognizes Tiga1 protein
(Figure 3A). Since incubation of E.coli at 37 C appeared to
generate degraded products, we incubated the cells at 20 C
for large scale preparation of GST-Tiga1 protein.
We used the anti-Tiga1 antibody to analyze the cell
extracts of TIG-1 cells that had entered G0 phase due to
serum starvation. Western blot analysis of these extracts
revealed that the antibody recognized a band at 26 kDa
(Figure 3B), which is larger than the expected size of Tiga1
(13 kDa). However, since the band intensity increased during
serum starvation, this band appears to be the band for Tiga1.
To conﬁrm this, we performed another Western blot analysis
using a different set of size markers and again detected a sin-
gle band at 26 kDa (Figure 3C). It is likely that this band con-
tains Tiga1 protein that has been modiﬁed in some way. Thus,
it appears that TIGA1 is also regulated at the posttranscrip-
tional level, as both its protein levels are upregulated and
its protein structure is modiﬁed.
Ectopic TIGA1 expression inhibits the colony-forming
ability of tumor cells
To determine if the transcriptional induction of TIGA1 after
serum deprivation causes the cellular growth arrest, we
evaluated the effect of ectopic expression of TIGA1 on the
proliferation of tumor cells, as these cells are unable to
enter the G0 phase. To do so, we performed colony formation
assays. Thus, we transiently transfected the lung cancer cell
line EBC-1, which does not express any TIGA1 transcripts
(Figure 2C), with an hemagglutin (HA)-TIGA1-expressing
vector (pcDNA3-HA-TIGA1) that harbors a neomycin resis-
tance gene. The transfected cells were cultured for 2 weeks
in medium containing G418 to select the cells, and number
of survival colonies were counted. As a positive control,
EBC-1 cells were transfected with a plasmid harboring
p53 cDNA, which induces growth arrest. As a negative
control, the cells were transfected with plasmid alone. As
shown in Figure 3, the EBC-1 cells that constitutively express
Tiga1 show a signiﬁcant reduction in both colony number
and size, as compared to cells transfected with vector alone
(Figure 4A). Moreover, TIGA1 expression reduced the
colony-forming efﬁciency by 70% compared to cells trans-
fected with the vector alone (Figure 4B). This level of
reduction was slightly weaker than that induced by transfec-
tion with wild-type p53. These results indicate that ectopic
expression of TIGA1 inhibits cell proliferation, which
suggests that TIGA1 may trigger the growth arrest process.
Ectopic TIGA1 expression inhibits tumor growth in
soft agar
To know the role of TIGA1 as a tumor suppressor, we exam-
ined whether ectopic expression of TIGA1 could suppress the
anchorage-independent growth. To introduce the TIGA1 gene
into human cancer cell lines, we made an amphotropic retro-
virus carrying with TIGA1 gene. TIGA1 retrovirus and control
retrovirus were introduced into the bladder carcinoma cell
line T24 and the osteosarcoma cell line SaOS-2. As shown
in Figure 5A, TIGA1 infected cells inhibited the growth of
these cells in soft agar.
We also examined the effect of TIGA1 overexpression in
the expression-inducible EcR-293 cell line that constitutively
expresses the recombinant ecdysone receptor (30). Thus,
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Figure 2. Structure and expression of TIGA1 in human tissues and human cancer cells. (A) Schematic representation of the Tiga1 protein (120 amino acids) that
shows its transmembrane (TM) region. (B) Analysis of TIGA1 expression in human multiple tissue Northern blots (Clontech). b-actin cDNA served as a loading
control. (C) Northern blot analysis of TIGA1 expression in human lung cancer cells. GAPDH served as a loading control. The northern blots were probed with
32P-labeled TIGA1 cDNA.
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fected into EcR-293 cells and selected for 2 weeks in G418
and zeocin containing medium. Drug resistant cells were
pooled and expression of Tiga1 protein was induced by ecdy-
sone successfully as shown in Figure 5B. The ectopically
expressed Tiga1 protein migrated at the rate expected for a
120 amino acid protein, which suggests that Tiga1 is not
post-translationally modiﬁed in rapidly growing EcR-293
cells. Using these cells, we examined the effect of overex-
pression of TIGA1 on cell proliferation and anchorage-
independent growth. In the soft agar assay, ecdysone-induced
TIGA1 expression signiﬁcantly inhibited the growth of the
EcR-293 cells (Figure 5A). The introduction of vector
alone had no apparent effect. Figure 5C shows a typical
image exemplifying the Tiga1-mediated inhibition of EcR-
293 cell growth in soft agar. We also showed that HA-
Tiga1 expression induced by ecdysone inhibited the growth
of pIND-HA-Tiga1-transfected EcR-293 cells that were cul-
tured in normal growth medium in the presence of ecdysone
(Supplementary Figure S3). Thus, ectopic overexpression
of TIGA1 inhibits both the anchorage-dependent and
independent growth of tumor cells.
Subcellular localization of Tiga1
We next investigated the subcellular localization of Tiga1 by
constructing a GFP-Tiga1 fusion protein-expressing plasmid
and transfecting COS-7 cells with it. The growth of the
COS-7 cells looked normal for a few days after transfection
but the growth rate then decreased gradually and eventually
stopped altogether (data not shown). When we observed the
subcellular localization of GFP-Tiga1 2 days after transfec-
tion, we found that it had a granule-like cytoplasmic distribu-
tion (Figure 6A, upper panel). This suggests that Tiga1 is
localized in the microsome of the cytoplasm but not in the
cellular membrane. This distribution was distinct from the
diffuse distribution of EGFP throughout the cytoplasm in
GFP-expressing recombinant cells (Figure 6A, lower panel).
The localization of GFP-Tiga1 in the mitochondria was con-
ﬁrmed by staining GFP-Tiga1-expressing HeLa cells with the
mitochondrial staining marker MitoTracker. As expected,
when GFP-Tiga1 was exogenously expressed in HeLa cells,
it co-localized with MitoTracker (Figure 6B).
We next performed a protease protection assay to deter-
mine the direction Tiga1 is inserted in the mitochondrial
membrane. HeLa cells were transfected with a plasmid
A
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Figure 3. Western blot analysis using an anti-Tiga1 antibody. (A) Anti-Tiga1 antibody specifically recognizes Tiga1 protein when Escherichiacoli cells that can
express GST-Tiga1 protein were incubated in the absence ( ) or presence of isopropyl b-D-thiogalactoside (IPTG) at 20 or 37 C to induce expression of GST-
Tiga1 protein. (B) Western blot analysis using this anti-Tiga1 antibody yielded a band for endogenous Tiga1 protein at 26 kDa. An asterisk denotes the putative
nonspecific band. Ponceau S staining of the polyacrylamide gel is presented as a loading control. (C) Western blot analysis with a new set of size markers. The
reproducibility of the migration of the band for Tiga1 at 26 kDa was confirmed. Asterisks denote the putative nonspecific band.
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6Myc (6Myc-Tiga1). The cells were digested with various
amounts of trypsin in the presence or absence of Triton
X-100 for 15 min, boiled in sample buffer and the lysates
were subjected to Western blot analysis with the anti-Myc
antibody. The presence of Triton X-100 itself had no effect
on the size of the 6Myc-Tiga1 protein (Figure 6C, lanes 1
and 5) but 0.5 and 1 mg trypsin digestion completed digested
6Myc-Tiga1. However, while 0.25 mg trypsin failed to
destroy 6Myc-Tiga1 in the absence of 1% Triton X-100
(Figure 6C, lanes 2–4), the presence of Triton X-100
facilitated the trypsin-mediated destruction of 6Myc-Tiga1
(Figure 6C, lanes 2–6). This result suggests that the
N-terminus of Tiga1 is localized in the mitochondria while
its C-terminus is in the cytoplasm.
Both the N- and C-terminal portions of Tiga1 are
responsible for its mitochondrial localization and
cellular toxicity
To examine which region of Tiga1 is required for its mito-
chondrial localization, we fused GFP to various Tiga1 dele-
tion constructs (Figure 7A) and expressed them in HeLa
cells. We found that most of the intact (full-size) Tiga1
fused with GFP (denoted as Tiga1-full in Figure 6B) coloca-
lized with cytochrome c, which is also in the mitochondria as
revealed by MitoTracker (Figure 7B). While some of the
GFP-Tiga1-a and GFP-Tiga1-b proteins also colocalized
with cytochrome c, they did so much less frequently than
GFP-Tiga1-full. Almost no colocalization was observed for
the GFP-Tiga1-c protein. These results indicate that while
both of the N-terminal and C-terminal regions around the
transmembrane domain are required for the mitochondrial
localization of Tiga1, the former plays a more important role.
During these experiments, we noted that few of the cells
expressing GFP-Tiga1 were viable, unlike the cells that
expressed the GFP vector alone. Western blot analysis also
showed that expression of GFP-Tiga1 was very low com-
pared to GFP alone (Figure 7C). This suggests that GFP-
Tiga1 is toxic to cultured cancer cells. To eliminate the
possibility that the low expression of GFP-Tiga1 was due
to low transcription-translation efﬁciency, we compared the
frequencies of the GFP-expressing cells and the live cells
that carry each deletion mutant form of Tiga1. When vector
alone was expressed, >60% of the cells showed the GFP
signal (Figure 7D). In contrast, a very low frequency of
A
B
Figure 4. Ectopic expression of TIGA1, like p53, inhibits the colony-forming
ability of EBC-1 cells. (A) Equal amounts (2 mg) of plasmid encoding a
neomycin resistance gene alone (pcDNA3-HA, vector) or the same vector
containing TIGA1 (pcDNA3-HA-TIGA1) or p53 (pcDNA3-Flag-p53)
cDNAs, were transfecte into EBC-1 cells. After growth for 2 weeks in
medium containing G418, the plates were fixed and stained with crystal violet
to identify the surviving colonies. (B) The reproducibility of the result was
confirmed by repeating the experiment three times. Bar graphs that
summarize the results from three independent experiments (each in
triplicate). Error bars indicate the SDs of the mean.
A
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Figure 5. Ectopic Tiga1 expression suppresses the anchorage-independent
growth of Saos-2, T24 and EcR-293 cells. (A) Saos-2 and T24 cells were
infected by the pCXbsr vector virus (Vector) or the recombinant virus
containing HA-tagged Tiga1 (Tiga1). Ecdysone-inducible 293 (EcR-293)
cells were stably transfected with the pIND vector alone (pIND) or pIND-
HA-Tiga1 (Tiga1) and treated with (+) or without ( )1mM muristerone A, a
synthetic analogue of ecdysone. All cells were inoculated into soft agar, and
the growing colonies were scored after incubation for 10 days. The number
above each bar in the graph indicates relative colony formation efficiency.
The reproducibility of the result was confirmed by repeating the experiment
three times. Error bars indicate the SDs of the mean. (B) The colonies
generated by the EcR-293 cells bearing the pIND vector or pIND-HA-Tiga1
as shown in (A) were photographed. (C) Induction of HA-tagged Tiga1
expression in EcR-293 cells by muristerone A. The cell lysates from the EcR-
293 cells shown in (A) and (B) were resolved by SDS–PAGE, followed by
western blotting with anti-HA antibody.
Nucleic Acids Research, 2006, Vol. 34, No. 17 4885cells displayed the GFP signal when they expressed
GFP-Tiga1-full or GFP-Tiga1-c. In contrast, cells expressing
GFP-Tiga1-a or GFP-Tiga1-b showed less severe toxicity.
This is independent of their co-localizations with cytochrome
c, as described above (Figure 7A). Thus, the entire
C-terminus region is responsible for the cellular toxicity of
Tiga1.
Analysis of the microsatellite marker ENDL-1 reveals
LOH of the TIGA1 allele in cancer cells
It has been reported that LOH at 5q21–22, which contains the
TIGA1 allele, is frequently observed in the cell lines and tis-
sues of lung cancer patients (28). To investigate whether
LOH is also detected at a locus proximal to TIGA1 gene,
we designed a new microsatellite marker, namely, ENDL-1,
which consists of (TA)23 and (CA)11 repeats and is located
 75 kb from the 50 end of the TIGA1 gene (Figure 8A
and B). We subjected small-cell lung cancer (SCLC), non
SCLC (NSCLC) and various other cell lines to LOH analysis
with ENDL-1. Normal TIG-1 cells exhibited two bands that
correspond to the two alleles from the mother and father. In
contrast, a single band was detected for most of the SCLC
and NSCLC lung cancer cell lines we tested, namely,
Lu-24, Lu-130, Lu-134, Lu-135, Lu-140 and H69 of the
SCLC lines and EBC-1, Lu-65, PC-3, PC-7 and PC-10 of
the NSCLC lines. Only one SCLC (Lu-139) and one
NSCLC (A549) line had both alleles. Moreover, we also
found LOH in other cancer cell lines, namely, MCF-7, Jurkat
and HL60 (Figure 8C). That both leukemia cell lines (Jurkat
and HL60) showed LOH is consistent with a study that found
a high degree of LOH in this region in patients with acute
myeloid leukemias and acute lymphoblastic leukemias (31).
Thus, we conclude that the region of the genome that is
in the vicinity of the TIGA1 gene is frequently deleted in
many cancer cell lines and that ENDL-1 can serve as an
informative microsatellite marker for this LOH.
DISCUSSION
Serum starvation and contact inhibition induce distinct
G0 phases
In the present study, we isolated 44 TIGA genes from human
primary culture ﬁbroblast (TIG-1) cells whose mRNA levels
are upregulated by serum starvation and/or contact inhibition.
Our isolation of TIGA genes here has clariﬁed two issues.
First, while some TIGA genes are upregulated by both
serum starvation and contact inhibition, other TIGA genes
respond to one or the other stimulation but not both
(Figure 1 and Supplementary Figure 1S). For example,
TIGA2, TIGA14, TIGA20 and TIGA120 may be involved in
G0-s alone because contact inhibition had little to no effect
on the expression of these genes. In contrast, the Group III
TIGA genes may be predominantly involved in G0-c alone
because they exhibited very low responses after serum
starvation (Supplementary Figure 1S). Meanwhile, TIGA6,
TIGA104, TIGA110, TIGA111, TIGA117 and TIGA122 may
be involved in both G0-s and G0-c phases since both serum
starvation and contact inhibition induced their strong
responses. Thus, while G0-s and G0-c are partly regulated
by the same genes, distinct mechanisms that are mediated
by speciﬁc genes are also involved. Second, we identiﬁed a
point of entry into the deep G0 phase at Day 3 of serum
starvation. This point is referred to here as the ‘G0 gate’.
Fourteen TIGA genes (Group I) are abruptly upregulated at
the G0 gate and their mRNA levels remained almost constant
afterwards (Figure 1B and C). Notably, the expression of the
six MCM2-7 genes that are induced at the initiation of S
phase of the mitotic cell cycle (16) is abruptly downregulated
after Day 3 of serum starvation (Figure 1A). This further
supports the existence of a ‘G0 gate’ at which point the
expression of growth-promoting genes cease.
The deﬁnition of the G0 gate as the expression of the 14
TIGA genes after 3 days of serum starvation helps us to better
understand the previously ambiguously deﬁned G0 phase.
Earlier studies have shown that G0 can be induced by short
serum starvation, namely, a few hours or less (2,32). In
these papers, the evidence for G0 arrest was that the cells
needed time (6–8 h) to return to the cell cycle. This feature
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Figure 6. Subcellular localization of GFP-tagged Tiga1. (A) Microscopic
images of the fluorescence emitted by the GFP proteins (right). COS-7 cells
were transfected with plasmid DNAs expressing GFP-tagged Tiga1 or GFP
alone and examined under a microscope after 48 h of incubation. The
differential interference contrast (DIC) images are shown on the left. (B)
Microscopic images of the fluorescence emitted by GFP or MitoTracker in
HeLa cells transfected with a plasmid expressing GFP-tagged Tiga1. The
cells were treated with MitoTracker before chemical fixing. Merged images
are also shown. The GFP and MitoTracker signals are green and red,
respectively, and the merged signals are yellow. (C) Protease protection assay
to determine the orientation of Tiga1 in the mitochondrial membrane. HeLa
cells expressing 6Myc-Tiga1 were digested with various amounts of trypsin
(lanes 1 and 5, 0 mg/ml; lanes 2 and 6, 0.25 mg/ml; lanes 3 and 7, 0.5 mg/ml;
lanes 4 and 8, 1 mg/ml) in the absence (lanes 1–4) or presence (lanes 5–8) of
1% Triton X-100, followed by boiling and Western blot analysis with an anti-
Myc antibody (PL14).
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serum starvation. On the basis of these observations, we pos-
tulate that the G0 phase that induced after a few hours of
serum starvation should be called ‘shallow G0’ (or G0/G1
phase) while the G0 phase generated by 3 days of serum
starvation should be called ‘deep G0’. Since the G0 gate
only opens after 3 days of serum starvation, it separates the
shallow G0 phase from the deep G0 phase. Further studies
will be needed to determine how the shallow and deep G0
phases differ. With regard to the role Tiga1 protein plays in
shallow and deep G0, we know that its levels are dramatically
increased in deep G0 (Figures 1B and 3). As described below,
it is likely to act in the mitochondria to control the fuel
consumption of the cells, thereby maintaining the low meta-
bolism of the cells in shallow G0 and more importantly in
deep G0.
Recent genome-wide analysis has revealed a large number
of genes that are either upregulated or downregulated upon
serum starvation or contact inhibition (33). To our surprise,
none of the TIGA genes were not detected by this analysis
except for TIGA20 (eIF3) (which, unlike our observations,
is listed as a G0-downregulated gene). Moreover, this study
did not ﬁnd that MCM5 is downregulated upon serum star-
vation, although it was listed it as a gene that is upregulated
by contact inhibition. It is not known whether these discre-
pancies are due to differences in the experimental systems
used. Since these authors did not conﬁrm their DNA chip
data by Northern blot analysis or quantitative RT–PCR, it
is difﬁcult to compare their results with ours.
Some TIGA genes regulate cell growth
By examining the structure of the TIGA gene products, we
noticed that some of them are involved in regulation of cell
growth. For example, TIGA20 (¼eIF3; eukaryotic translation
initiation factor 3) is known to stimulate the recruitment of
the eIF2-GTP-Met-tRNAiMet ternary complex to the 40S
ribosome along with other initiation factors, including eIF1,
eIF5 and eIF1A (34). Consequently, it may enhance the
translation of the mRNAs that are left intact in G0-s phase
cells. Its expression is probably important in G0-s because
some mRNAs are present in G0 cells at markedly reduced
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Figure 7. Both its N- and C-terminal regions are required for the mitochondrial localization of Tiga1. (A) Schematic presentation of GFP-fused Tiga1 deletion
constructs. The N-terminal portion of Tiga1 is within the mitochondria while its C-terminal portion is in the cytoplasm. (B) Microscopic images of HeLa cells
that express the various GFP-Tiga1 deletion constructs or GFP vector alone. GFP-Tiga1 proteins were visualized by staining with anti-GFP antibody (green)
while cytochrome c was detected by anti-cytochrome c antibody (Promega) and Alexa 594-conjugated anti-mouse IgG antibody (red). The nuclei were stained
with DAPI (blue). (C) Western blot analysis of the total cell extracts obtained from HeLa cells transfected with the GFP-fused Tiga1 deletion constructs. The
GFP-Tiga1 fusion proteins were detected by anti-GFP antibody (clone J1). Tubulin served as a loading control. (D) Percentages of cytochrome c-expressing cells
versus GFP-expressing cells for each plasmid construct.
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Figure 8. The TIGA1 gene locus in cancer cells exhibits LOH. (A) Schematic depiction of the chromosomal localization of the TIGA1 gene. (i) The banding
pattern of human chromosome 5 that illustrates the localization of TIGA1 in 5q22.2. (ii) Map of chromosome 5 and the corresponding contigs in 5q22.2. The
locations of the FER tyrosine kinase gene and the APC gene, which are frequently deleted in cancer cells (28), are indicated. (iii) Two DNA fragments from
GenBank cover part of the contig NT006710.2. A vertical arrow indicates the locus of the microsatellite marker ENDL-1. (iv–vi) Schematic representation of the
TIGA1 gene, TIGA1 cDNA and Tiga1 protein. TIGA1 is composed of three exons and encodes an ORF of 120 amino acids (aa). (B) DNA sequences around the
microsatellite marker ENDL-1 that were used for the PCR amplifications. The PCR primer sequences are shown by horizontal arrows. Dotted and bolded
underlines denote the (AT)22 and (CA)11 repeats, respectively. (C) Analysis of LOH at ENDL-1 in normal (TIG-1) or cancer cells. Cells showing the presence of
two alleles are denoted by asterisks at the top of each lane, while cells showing only one allele (i.e. LOH) are indicated by vertical arrowheads. The
electrophoretic patterns of the radiolabeled probes in 6% polyacrylamide gel are shown.
4888 Nucleic Acids Research, 2006, Vol. 34, No. 17quantities, and the enhanced activation of their translation is
needed to keep the cells alive in G0-s. Notably, eIF3 is not
elevated in G0-c phase cells, which conﬁrms the possibility
that the G0-s and G0-c phases are regulated differently.
TIGA16 (¼DEPP; decidual protein induced by progester-
one) encodes one of the progesterone or androgen-inducible
genes that can enhance the levels of phosphorylated Erk,
which in turn activates the Elk-1 transcription factor (35).
Thus, DEPP may act as a G0 signal that regulates the silen-
cing of many target genes. TIGA9 encodes paralemmin, a
novel lipid-anchored protein that is highly expressed in
neuronal plasma membranes. It has been implicated as a
potent modulator of cellular cAMP signaling within the
brain by speciﬁcally interacting with the third intracellular
loop of the D3 dopamine receptor (36).
TIGA104 encodes A2M, which is an abundant plasma/
extracellular space protein that also regulates proteinase and
growth factor activities. A2M gene transcription is induced by
IL-6 through the action of STAT3 (37). Since its expression
is dramatically induced in both the deep G0-s and G0-c
phases, A2M may serve to ﬁll the extracellular space to main-
tain the G0 phase or to inhibit the activity of unknown
growth-promoting protease(s).
TIGA105 encodes the nuclear mitotic apparatus protein,
which cross-links microtubule ends at spindle poles and is a
substrate for covalent modiﬁcation by tankyrase-1, a PARP
[poly(ADP-ribose) polymerase] that is required for the
assembly of bipolar spindles in mitosis (38). TIGA120
encodes a protein that is similar to C53 (Cdk5 activator-
binding protein). C53 serves as an important regulatory
component of the G(2)/M DNA damage checkpoint that is
generated in response to genotoxic stress (39). Since C53
overexpression promotes Cdk1 activity and the nuclear accu-
mulation of cyclin B1, the induction of TIGA120 in only the
G0-s phase suggest that it may play a role in modulating Cdk/
Cyclin function to maintain the quiescent state.
TIGA122 encodes the lipocalin-type prostaglandin D2
synthase (PTGDS), which is a key enzyme in the arachidonic
acid metabolism pathway, whose enzyme-derived metabo-
lites inhibit cell proliferation (40). It appears that this enzyme
is required for G0 cells to remain in the quiescent state
because its expression is not only increased when the cells
entered the deeper G0-s phase, it is also abruptly induced
after 6–10 days of contact inhibition. This observation is
interesting because an anti-inﬂammatory drug NS-398 that
inhibits prostaglandin synthesis reduced cell proliferation in
ovarian carcinoma cells by inducing G0/G1 cell cycle arrest
(41). Our result suggests that the bona ﬁde target of NS-398
may be PTGDS rather than COX-2.
Mutations of some TIGA genes cause hereditary disease
We also noticed that some TIGA genes are the responsible
genes for human hereditary diseases, which indicates that
their functions are important for proper maintenance of the
body. For example, TIGA3 (¼BBS1) is one of the six genes
whose dysfunction causes the genetically heterogeneous dis-
order Bardet-Biedl syndrome (BBS), which is characterized
primarily by retinal dystrophy, obesity, polydactyly, cogni-
tive impairment and gonadal and renal dysgenesis (42).
BBS1 (593 aa) is ubiquitously expressed in human tissues,
probably because most of the cells in the body are in G0
phase. BBS patients and BBS1-defective Tubby mice have
defects in ciliated neuron function and obesity, suggesting a
metabolic signaling axis from ciliated neurons to fat storage
tissues. Studies on the BBS1 homolog in Caenorhabditis
elegans revealed its coordinate regulation with a 3-ketoacyl-
coA thiolase that acts in fat storage tissue (43).
TIGA14 encodes ALMS1, a protein whose dysfunction
causes the autosomal recessive disease Alstrom syndrome,
which is characterized by cone-rod retinal dystrophy, cardio-
myopathy and type 2 diabetes mellitus (44,45). The ALMS1
gene encodes a large protein of 4169 amino acids containing
a large tandem-repeat domain comprised of 34 imperfect
repetitions of 47 amino acids. Six different mutations in
ALMS1 were detected in seven families with Alstrom syndro-
me, which conﬁrms that ALMS1 is the gene that underlies this
syndrome (44,45). While ALSM1 is ubiquitously expressed in
human tissues as detected by RT–PCR (44), it is highly
expressed in the heart, placenta, skeletal muscle, pancreas
and testis, as determined by Northern blot analysis (45).
TIGA119 encodes LIMK1, which commonly suffers
deletion in Williams syndrome (WS). WS is characterized
by dysmorphic features, mental retardation or learning difﬁ-
culties, elastin arteriopathy, and striking neurocognitive and
social-behavioral abnormalities (46). LIMK1 plays an impor-
tant role in cell motility by phosphorylating and inactivating
the actin depolymerization factor coﬁlin, and regulates actin
cytoskeletal changes (47). It is also involved in microtubule
destabilization (48).
Putative function of the Tiga1 protein and evolution of
the TIGA1 gene
To determine whether the ectopic expression of the TIGA
genes would inhibit the perpetual growth of cancer cells,
we selected TIGA1, one of the uncharacterized genes, for
further functional analysis. We found that the ectopic
expression of TIGA1 inhibited not only tumor cell growth
in medium (Figure 4 and Supplementary Figure S3) but
also anchorage-independent tumor cell growth in soft agar
(Figure 5). We also found that Tiga1, which is a small protein
with a single transmembrane domain, is localized in the
mitochondria (Figures 6 and 7). Moreover, ectopic expression
of TIGA1 was toxic to cultured cancer cells. This may be due
to the aberrant cytochrome c release and mitochondrial
membrane permeability that is induced by ectopic Tiga-1
expression. As discussed below, the homology of Tiga1 to
cyanate permease and the ABC transporter of bacteria sup-
ports the notion that Tiga1 is a regulator of ion transport in
the mitochondrial transmembrane. This is also suggested by
the fact that the growth inhibition and G0/G1 arrest induced
by the histone deacetylase inhibitor MS-275 is caused by the
loss of mitochondrial transmembrane potential (49). Further-
more, by using the ENDL-1 microsatellite marker, we could
detect LOH around the TIGA1 gene region in many cancer
cells, including SCLCs and NSCLCs (Figure 8). Thus,
ENDL-1 may be an useful marker to detect deletions in
chromosome 5q21–22.
Curiously, TIGA1 is found only in primates and no
homologous genes were found in any other vertebrates. How-
ever, homologous proteins were found in yeast and bacteria
Nucleic Acids Research, 2006, Vol. 34, No. 17 4889(Figure 9). The functions of these homologues are all some-
how related to ion transport. That most of the Tiga-1 protein
(78 of 120 amino acids) showed marked similarity (28%
identical) to cyanate permease (a CynX-related transport
protein) suggests that Tiga1 is involved in inorganic ion
transport and metabolism. This is supported by the marked
similarity of Tiga1 to the ABC transporter (permease). It is
also notable that two of the Tiga1-homologue-bearing
species identiﬁed to date are in symbiotic relationships;
Bradyrhizobium japonicum is a nitrogen-ﬁxing bacterium
that develops a symbiotic relationship with the soybean
plant (50), while Sodalis glossinidius is a maternally trans-
mitted secondary endosymbiont that resides intracellularly
in the tissues of the tsetse ﬂy (51). Interestingly, most of
the Tiga1 protein (78 of 120 amino acids) shows particularly
extensive similarities (37% identical) to the glycerol-3-
phosphate regulon protein GlpG of S.glossinidius.T h i s
suggests that the TIGA1 gene may have entered the human
genome after mice and humans separated. The existence of
TIGA1-like genes in chimpanzees (Pan troglodytes) and
Figure 9. Homology of Tiga1 with various proteins as determined by BLAST homology searching. Identical and homologous (+) amino acids are indicated.
TIGA1 ortholog exists only in primates but not in other organisms. Homologous protein of Tiga1 is found only in yeast and bacteria.
4890 Nucleic Acids Research, 2006, Vol. 34, No. 17rhesus monkeys (Macaca mulatta) indicate that this event
occurred before human beings diverged from monkeys. It is
possible that the TIGA-1 gene entered monkeys in Africa
by a tsetse ﬂy transposon. This possibility suggests that
TIGA-1 could serve as a molecular clock in the construction
of a tree describing primate evolution; this tree could be
useful for studying the evolution of human beings.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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